LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Accounts Payable

As of the most recent data (June 2026), LFMDP shows a accounts payable of $18M. That compares with $24M in the prior-year period — down 25.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LFMDP's accounts payable is now $18M (was $24M) — a 25.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is outperforming or lagging.

Tracking LFMDP's accounts payable over time shows whether LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $18M That compares with $24M in the prior-year period — down 25.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $18M) with ownership activity and broader fundamentals.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's accounts payable is $18M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.